Discover 815 paid clinical trials in Jacksonville, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Jacksonville currently offers many active clinical trials, particularly in the areas of diabetes, cardiovascular health, and chronic pain management. With opportunities for both healthy volunteers seeking paid studies, as well as those looking for trials tailored to specific conditions, these trials offer participants access to cutting-edge treatments while advancing healthcare.
Filter
2
Filter results
Results: 815
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Lake City FL, Jacksonville FL, Ormond Beach FL,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase3, Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Jacksonville FL, New Port Richey FL, Tampa FL, Macon GA,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase2, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Jacksonville FL, Saint Augustine FL, Fleming Island FL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
for
Chronic Migraine
Location: Jacksonville FL, Port Royal SC, Lakeland FL,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018713
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis